FewerJobs.
All jobs

Director, Revenue Accounting and Finance

Revolution Medicines - Remote (United States)

Posted Oct 15, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Not verified checked Nov 20, 2026
Salary
$201K-$251K From the posting source checked Nov 16, 2026
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)
$106,409 U.S. median for this role
Projected growth (BLS Employment Projections)
+7.7% - Faster than average

112% above the BLS role benchmark for finance aggregate.

Matched to SOC 13-2011 - Finance aggregate by role bucket.

Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.

Role

Role function
Finance From the posting source checked Nov 16, 2026
Seniority
Director Plus From the posting source checked Nov 16, 2026
Work mode
Remote From the posting source checked Nov 16, 2026
In-office days
0 days From the posting source checked Nov 16, 2026

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source checked Nov 16, 2026

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Director, Revenue Accounting and Finance Remote (United States) Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: Revolution Medicines is seeking a Director, Revenue Accounting and Finance to provide leadership across revenue accounting, gross to net accounting and forecasting, and related commercial finance activities as the company continues to scale its commercial operations. Reporting to the Senior Director, Revenue Accounting and Finance, this role will lead critical revenue and gross to net processes, including financial close, forecasting, controls, government pricing coordination, analytics, and global revenue reporting. The Director will balance strong operational execution with longer term process development, helping establish scalable methodologies, controls, and reporting capabilities to support the company's continued commercial growth. This individual will serve as a senior Finance partner to Commercial, Market Access, Analytics & Insights, Corporate Accounting, FP&A, and regional Finance teams. The ideal candidate will bring deep pharmaceutical revenue and gross to net

Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.

Apply at revmed.com

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs